Dr. Cohen on Immunotherapy Combinations in Head and Neck Cancer

Ezra Cohen, MD

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses immunotherapy combinations in head and neck cancer.

Combinations that incorporate IDO inhibitors, STAT-3 inhibitors, and anti-KIR monoclonal antibodies, are doubling and even tripling response rates in patients with head and neck cancer, says Cohen.
Printer Printing...